{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:05:54Z","timestamp":1784246754431,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-72912-9","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:24:10Z","timestamp":1778873050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Towards hepatitis C elimination with integrated risk-based screening and decentralized care in Taiwan"],"prefix":"10.1038","volume":"17","author":[{"given":"Yen-Po","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3595-1570","authenticated-orcid":false,"given":"Abbie Ting-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Lei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ling","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chen","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0628-8768","authenticated-orcid":false,"given":"Amy Ming-Fang","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9750-3015","authenticated-orcid":false,"given":"Sam Li-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8586-0277","authenticated-orcid":false,"given":"Chen-Yang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Chih","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dih-Ling","family":"Luh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Nan","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Easterbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9172-1967","authenticated-orcid":false,"given":"Tsung-Hui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5799-6705","authenticated-orcid":false,"given":"Tony Hsiu-Hsi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the Changhua Hepatitis C Elimination Task Force Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"72912_CR1","unstructured":"World Health Organization. Implementing the global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022-2030: report on progress and gaps 2024, second edition (World Health Organization, 2024)."},{"key":"72912_CR2","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.jfma.2018.10.021","volume":"117","author":"GH Wu","year":"2018","unstructured":"Wu, G. H., Pwu, R. F. & Chen, S. C. Achieving hepatitis C elimination in Taiwan\u2014overcoming barriers by setting feasible strategies. J. Formos. Med. Assoc. 117, 1044\u20131045 (2018).","journal-title":"J. Formos. Med. Assoc."},{"key":"72912_CR3","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jfma.2020.04.003","volume":"119","author":"ML Yu","year":"2020","unstructured":"Yu, M. L. et al. 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population. J. Formos. Med. Assoc. 119, 1019\u20131040 (2020).","journal-title":"J. Formos. Med. Assoc."},{"key":"72912_CR4","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0929-6646(09)60231-X","volume":"106","author":"CH Chen","year":"2007","unstructured":"Chen, C. H. et al. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J. Formos. Med. Assoc. 106, 877\u2013886 (2007).","journal-title":"J. Formos. Med. Assoc."},{"key":"72912_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s12072-023-10605-x","volume":"18","author":"TY Lin","year":"2024","unstructured":"Lin, T. Y. et al. Planning, implementing, and evaluating hepatitis C virus elimination via collaborative community-based care cascade: age-period-cohort model for estimating demand from antecedent anti-HCV survey. Hepatol. Int. 18, 476\u2013485 (2024).","journal-title":"Hepatol. Int."},{"key":"72912_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jhep.2020.09.008","volume":"74","author":"G Shiha","year":"2021","unstructured":"Shiha, G. et al. Reduced incidence of hepatitis C in nine villages in rural Egypt: progress towards national elimination goals. J. Hepatol. 74, 303\u2013311 (2021).","journal-title":"J. Hepatol."},{"key":"72912_CR7","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1016\/S2214-109X(19)30483-8","volume":"8","author":"JG Walker","year":"2020","unstructured":"Walker, J. G. et al. Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study. Lancet Glob. Health 8, e244\u2013e253 (2020).","journal-title":"Lancet Glob. Health"},{"key":"72912_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/cid\/ciad182","volume":"77","author":"L Gvinjilia","year":"2023","unstructured":"Gvinjilia, L. et al. Impact of hepatitis C virus infection and treatment on mortality in the country of Georgia, 2015-2020. Clin. Infect. Dis. 77, 405\u2013413 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"72912_CR9","doi-asserted-by":"publisher","first-page":"2200952","DOI":"10.2807\/1560-7917.ES.2023.28.30.2200952","volume":"28","author":"JG Walker","year":"2023","unstructured":"Walker, J. G. et al. Insights from a national survey in 2021 and from modelling on progress towards hepatitis C virus elimination in the country of Georgia since 2015. Eur. Surveill. 28, 2200952 (2023).","journal-title":"Eur. Surveill."},{"key":"72912_CR10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/j.1365-2893.2009.01115.x","volume":"16","author":"EM Lehman","year":"2009","unstructured":"Lehman, E. M. & Wilson, M. L. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J. Viral Hepat. 16, 650\u2013658 (2009).","journal-title":"J. Viral Hepat."},{"key":"72912_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S2468-1253(21)00311-3","volume":"7","author":"A Artenie","year":"2022","unstructured":"Artenie, A. et al. Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHO. Lancet Gastroenterol. Hepatol. 7, 353\u2013366 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"72912_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","volume":"7","author":"Polaris Observatory HCV Collaborators.","year":"2022","unstructured":"Polaris Observatory HCV Collaborators. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol. Hepatol. 7, 396\u2013415 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"72912_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/jvh.12248","volume":"21","author":"H Razavi","year":"2014","unstructured":"Razavi, H. et al. The present and future disease burden of hepatitis C virus infection with today\u2019s treatment paradigm. J. Viral Hepat. 21, 34\u201359 (2014).","journal-title":"J. Viral Hepat."},{"key":"72912_CR14","first-page":"S0929","volume":"25","author":"CC Yang","year":"2025","unstructured":"Yang, C. C. et al. Changhua Integrated Program to Stop HCV Infection (CHIPS-C): A county-wide model for integrated HCV elimination in Taiwan. J. Formos. Med. Assoc. 25, S0929\u2013S6646 (2025).","journal-title":"J. Formos. Med. Assoc."},{"key":"72912_CR15","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1002\/hep.26703","volume":"59","author":"YP Yeh","year":"2014","unstructured":"Yeh, Y. P. et al. Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan. Hepatology 59, 1840\u20131849 (2014).","journal-title":"Hepatology"},{"key":"72912_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jinf.2023.05.016","volume":"87","author":"TH Hu","year":"2023","unstructured":"Hu, T. H. et al. Enhancing testing and treatment uptake of HCV cascade care for the diabetes population via an integrated community-based shared care model. J. Infect. 87, 151\u2013152 (2023).","journal-title":"J. Infect."},{"key":"72912_CR17","unstructured":"World Health Organization. Access to hepatitis C testing and treatment for people who inject drugs and people in prisons: a global perspective. Policy brief (World Health Organization, 2019)."},{"key":"72912_CR18","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1016\/S2214-109X(23)00057-8","volume":"11","author":"L Degenhardt","year":"2023","unstructured":"Degenhardt, L. et al. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review. Lancet Glob. Health 11, e659\u2013e672 (2023).","journal-title":"Lancet Glob. Health"},{"key":"72912_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S2468-1253(19)30085-8","volume":"4","author":"A Trickey","year":"2019","unstructured":"Trickey, A. et al. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study. Lancet Gastroenterol. Hepatol. 4, 435\u2013444 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"72912_CR20","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jiph.2023.05.019","volume":"16","author":"WW Su","year":"2023","unstructured":"Su, W. W. et al. A new collaborative care approach toward hepatitis C elimination in marginalized populations. J. Infect. Public Health 16, 1201\u20131208 (2023).","journal-title":"J. Infect. Public Health"},{"key":"72912_CR21","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0140-6736(16)30466-4","volume":"388","author":"K Dolan","year":"2016","unstructured":"Dolan, K. et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet 388, 1089\u20131102 (2016).","journal-title":"Lancet"},{"key":"72912_CR22","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/hep.26387","volume":"58","author":"S Larney","year":"2013","unstructured":"Larney, S. et al. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology 58, 1215\u20131224 (2013).","journal-title":"Hepatology"},{"key":"72912_CR23","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S1473-3099(18)30469-9","volume":"18","author":"J Stone","year":"2018","unstructured":"Stone, J. et al. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect. Dis. 18, 1397\u20131409 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"72912_CR24","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","volume":"16","author":"L Platt","year":"2016","unstructured":"Platt, L. et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect. Dis. 16, 797\u2013808 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"72912_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1053\/j.ajkd.2021.03.017","volume":"78","author":"TH Hu","year":"2021","unstructured":"Hu, T. H. et al. Elimination of hepatitis C virus in a dialysis population: a collaborative care model in Taiwan. Am. J. Kidney Dis. 78, 511\u2013519.e1 (2021).","journal-title":"Am. J. Kidney Dis."},{"key":"72912_CR26","doi-asserted-by":"publisher","first-page":"883","DOI":"10.14309\/ajg.0000000000002624","volume":"119","author":"TH Hu","year":"2024","unstructured":"Hu, T. H. et al. Using the diabetes care system for a county-wide hepatitis C elimination: an integrated community-based shared care model in Taiwan. Am. J. Gastroenterol. 119, 883\u2013892 (2024).","journal-title":"Am. J. Gastroenterol."},{"key":"72912_CR27","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1440-1746.2009.05789.x","volume":"24","author":"ML Yu","year":"2009","unstructured":"Yu, M. L. & Chuang, W. L. Treatment of chronic hepatitis C in Asia: when East meets West. J. Gastroenterol. Hepatol. 24, 336\u2013345 (2009).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"72912_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/sres.2831","volume":"40","author":"CT Hsiao","year":"2023","unstructured":"Hsiao, C. T. et al. A systems view of responding to the COVID-19 pandemic: a causal loop model for Taiwan\u2019s approach. Syst. Res. Behav. Sci. 40, 194\u2013206 (2023).","journal-title":"Syst. Res. Behav. Sci."},{"key":"72912_CR29","doi-asserted-by":"publisher","first-page":"S180","DOI":"10.1093\/infdis\/jiad016","volume":"228","author":"RN Chien","year":"2023","unstructured":"Chien, R. N. et al. Policy and strategy for hepatitis C virus elimination at the national level: experience in Taiwan. J. Infect. Dis. 228, S180\u2013S188 (2023).","journal-title":"J. Infect. Dis."},{"key":"72912_CR30","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.jfma.2019.01.012","volume":"118","author":"CJ Chiang","year":"2019","unstructured":"Chiang, C. J., Wang, Y. W. & Lee, W. C. Taiwan\u2019s nationwide cancer registry system of 40 years: past, present, and future. J. Formos. Med. Assoc. 118, 856\u2013858 (2019).","journal-title":"J. Formos. Med. Assoc."},{"key":"72912_CR31","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/cncr.20171","volume":"100","author":"TH Chen","year":"2004","unstructured":"Chen, T. H. et al. Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer 100, 1734\u20131743 (2004).","journal-title":"Cancer"},{"key":"72912_CR32","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jhep.2019.11.004","volume":"72","author":"G Shiha","year":"2020","unstructured":"Shiha, G. et al. An educate, test and treat model towards elimination of hepatitis C infection in Egypt: feasibility and effectiveness in 73 villages. J. Hepatol. 72, 658\u2013669 (2020).","journal-title":"J. Hepatol."},{"key":"72912_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ijc.10122","volume":"98","author":"THH Chen","year":"2002","unstructured":"Chen, T. H. H. et al. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high-risk group in Taiwan. Int. J. Cancer 98, 257\u2013261 (2002).","journal-title":"Int. J. Cancer"},{"key":"72912_CR34","unstructured":"Spach, D. H. Natural history of hepatitis C infection. Hepatitis C Online. University of Washington; updated Available from: https:\/\/www.hepatitisc.uw.edu\/go\/evaluation-staging-monitoring\/natural-history\/core-concept\/all (2025)."},{"key":"72912_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/00130404-200409000-00009","volume":"10","author":"EW Yu","year":"2004","unstructured":"Yu, E. W., Chie, W. C. & Chen, T. H.-H. Does screening or surveillance for primary hepatocellular carcinoma with ultrasonography improve the prognosis of patients? Cancer J. 10, 317\u2013325 (2004).","journal-title":"Cancer J."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72912-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72912-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72912-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:45:43Z","timestamp":1784245543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72912-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72912"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72912-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6478"}}